FRAT1: A Drug Target / Disease Biomarker (G10023)

Target Name: FRAT1

NCBI ID: G10023

FRAT1

FRAT1: A Drug Target / Disease Biomarker

FRAT1, also known as farnesylated RNA-protein convertase, is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the regulation of RNA translation, which is the process by which proteins are synthesized from RNA.

FRAT1 has been identified as a potential drug target and has been shown to be involved in a variety of biological processes. One of the key functions of FRAT1 is its role in the regulation of cell growth and differentiation. It has been shown to play a key role in the regulation of cell proliferation and has been shown to interact with a variety of transcription factors.

In addition to its role in cell growth and differentiation, FRAT1 is also involved in the regulation of cellular signaling pathways. It has been shown to play a key role in the regulation of theNotch signaling pathway, which is a critical pathway involved in the regulation of cell proliferation and survival.

FRAT1 has also been shown to be involved in the regulation of inflammation. It has been shown to play a key role in the regulation of the NF-kappa-B signaling pathway, which is a critical pathway involved in the regulation of inflammation and immune responses.

In addition to its involvement in cellular signaling pathways, FRAT1 is also involved in the regulation of cellular processes that are important for the development and maintenance of the nervous system. It has been shown to play a key role in the regulation of synaptic plasticity, which is the ability of the nervous system to change and adapt over time.

FRAT1 is also involved in the regulation of the immune system, playing a key role in the regulation of T-cell development and function. It has been shown to play a key role in the regulation of the T-cell receptor, which is a critical receptor that is involved in the regulation of T-cell responses to foreign substances.

In conclusion, FRAT1 is a protein that is involved in a variety of important biological processes. As a potential drug target, FRAT1 has the potential to be developed into a new treatment for a variety of diseases. Further research is needed to fully understand the role of FRAT1 in cellular processes and to develop effective treatments based on this protein.

Protein Name: FRAT Regulator Of WNT Signaling Pathway 1

Functions: Positively regulates the Wnt signaling pathway by stabilizing beta-catenin through the association with GSK-3. May play a role in tumor progression and collaborate with PIM1 and MYC in lymphomagenesis

The "FRAT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRAT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets